{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:35:06Z","timestamp":1789544106954,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/cr.2016.69","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T06:44:30Z","timestamp":1464677070000},"page":"761-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["RANKL\/RANK control Brca1 mutation-driven mammary tumors"],"prefix":"10.1038","volume":"26","author":[{"given":"Verena","family":"Sigl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwadwo","family":"Owusu-Boaitey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purna A","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Kavirayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Wirnsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Novatchkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Kozieradzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schramek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnamdi","family":"Edokobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Hersl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishia","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Odai-Afotey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conxi","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonzalez-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Pujana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"for","family":"CIMBA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Heyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Sarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita","family":"Ticevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Uribesalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tortola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Pfeiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva YHP","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Bago-Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmuth","family":"Popper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Khokha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laundette P","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef M","family":"Penninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"key":"BFcr201669_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66\u201371.","journal-title":"Science"},{"key":"BFcr201669_CR2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/S1470-2045(13)70448-0","volume":"14","author":"M Widschwendter","year":"2013","unstructured":"Widschwendter M, Rosenthal AN, Philpott S, et al. The sex hormone system in carriers of BRCA1\/2 mutations: a case-control study. Lancet Oncol 2013; 14:1226\u20131232.","journal-title":"Lancet Oncol"},{"key":"BFcr201669_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1126\/science.1130471","volume":"314","author":"AJ Poole","year":"2006","unstructured":"Poole AJ, Li Y, Kim Y, Lin SC, Lee WH, Lee EY . Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 2006; 314:1467\u20131470.","journal-title":"Science"},{"key":"BFcr201669_CR4","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999; 13:2412\u20132424.","journal-title":"Genes Dev"},{"key":"BFcr201669_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397:315\u2013323.","journal-title":"Nature"},{"key":"BFcr201669_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009; 361:756\u2013765.","journal-title":"N Engl J Med"},{"key":"BFcr201669_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"MR McClung","year":"2006","unstructured":"McClung MR, Lewiecki EM, Cohen SB, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006; 354:821\u2013831.","journal-title":"N Engl J Med"},{"key":"BFcr201669_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJMoa0809003","volume":"361","author":"MR Smith","year":"2009","unstructured":"Smith MR, Egerdie B, Hernandez Toriz N, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 2009; 361:745\u2013755.","journal-title":"N Engl J Med"},{"key":"BFcr201669_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tem.2011.02.007","volume":"22","author":"D Schramek","year":"2011","unstructured":"Schramek D, Sigl V, Penninger JM . RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. Trends Endocrinol Metab 2011; 22:188\u2013194.","journal-title":"Trends Endocrinol Metab"},{"key":"BFcr201669_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","volume":"103","author":"JE Fata","year":"2000","unstructured":"Fata JE, Kong YY, Li J, et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000; 103:41\u201350.","journal-title":"Cell"},{"key":"BFcr201669_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nature09091","volume":"465","author":"PA Joshi","year":"2010","unstructured":"Joshi PA, Jackson HW, Beristain AG, et al. Progesterone induces adult mammary stem cell expansion. Nature 2010; 465:803\u2013807.","journal-title":"Nature"},{"key":"BFcr201669_CR12","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature09027","volume":"465","author":"ML Asselin-Labat","year":"2010","unstructured":"Asselin-Labat ML, Vaillant F, Sheridan JM, et al. Control of mammary stem cell function by steroid hormone signalling. Nature 2010; 465:798\u2013802.","journal-title":"Nature"},{"key":"BFcr201669_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature09387","volume":"468","author":"D Schramek","year":"2010","unstructured":"Schramek D, Leibbrandt A, Sigl V, et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010; 468:98\u2013102.","journal-title":"Nature"},{"key":"BFcr201669_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature09495","volume":"468","author":"E Gonzalez-Suarez","year":"2010","unstructured":"Gonzalez-Suarez E, Jacob AP, Jones J, et al. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 2010; 468:103\u2013107.","journal-title":"Nature"},{"key":"BFcr201669_CR15","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1073\/pnas.0711613105","volume":"105","author":"S Liu","year":"2008","unstructured":"Liu S, Ginestier C, Charafe-Jauffret E, et al. BRCA1 regulates human mammary stem\/progenitor cell fate. Proc Natl Acad Sci USA 2008; 105:1680\u20131685.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201669_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature08596","volume":"462","author":"R Hanada","year":"2009","unstructured":"Hanada R, Leibbrandt A, Hanada T, et al. Central control of fever and female body temperature by RANKL\/RANK. Nature 2009; 462:505\u2013509.","journal-title":"Nature"},{"key":"BFcr201669_CR17","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1038\/sj.onc.1206825","volume":"22","author":"TR Berton","year":"2003","unstructured":"Berton TR, Matsumoto T, Page A, et al. Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. Oncogene 2003; 22:5415\u20135426.","journal-title":"Oncogene"},{"key":"BFcr201669_CR18","doi-asserted-by":"publisher","first-page":"12111","DOI":"10.1073\/pnas.0702969104","volume":"104","author":"X Liu","year":"2007","unstructured":"Liu X, Holstege H, van der Gulden H, et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci USA 2007; 104:12111\u201312116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201669_CR19","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1158\/0008-5472.CAN-03-3524","volume":"64","author":"SC Lin","year":"2004","unstructured":"Lin SC, Lee KF, Nikitin AY, et al. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res 2004; 64:3525\u20133532.","journal-title":"Cancer Res"},{"key":"BFcr201669_CR20","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/gb-2013-14-11-r125","volume":"14","author":"AD Pfefferle","year":"2013","unstructured":"Pfefferle AD, Herschkowitz JI, Usary J, et al. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biol 2013; 14:R125.","journal-title":"Genome Biol"},{"key":"BFcr201669_CR21","doi-asserted-by":"publisher","first-page":"e1003212","DOI":"10.1371\/journal.pgen.1003212","volume":"9","author":"FJ Couch","year":"2013","unstructured":"Couch FJ, Wang X, McGuffog L, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 2013; 9:e1003212.","journal-title":"PLoS Genet"},{"key":"BFcr201669_CR22","doi-asserted-by":"publisher","first-page":"e1003173","DOI":"10.1371\/journal.pgen.1003173","volume":"9","author":"MM Gaudet","year":"2013","unstructured":"Gaudet MM, Kuchenbaecker KB, Vijai J, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 2013; 9:e1003173.","journal-title":"PLoS Genet"},{"key":"BFcr201669_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.2249","volume":"44","author":"K Estrada","year":"2012","unstructured":"Estrada K, Styrkarsdottir U, Evangelou E, et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012; 44:491\u2013501.","journal-title":"Nat Genet"},{"key":"BFcr201669_CR24","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ng.446","volume":"41","author":"F Rivadeneira","year":"2009","unstructured":"Rivadeneira F, Styrkarsdottir U, Estrada K, et al. Genetic Factors for Osteoporosis (GEFOS) Consortium, Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 2009; 41:1199\u20131206.","journal-title":"Nat Genet"},{"key":"BFcr201669_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"N Cancer Genome Atlas","year":"2012","unstructured":"Cancer Genome Atlas N . Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61\u201370.","journal-title":"Nature"},{"key":"BFcr201669_CR26","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/stem.2271","volume":"34","author":"A Cordero","year":"2016","unstructured":"Cordero A, Pellegrini P, Sanz-Moreno A, et al. Rankl impairs lactogenic differentiation through inhibition of the prolactin\/Stat5 pathway at midgestation. Stem Cells 2016; 34:1027\u20131039.","journal-title":"Stem Cells"},{"key":"BFcr201669_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1242\/dev.088948","volume":"140","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Gallego-Ortega D, Ledger A, et al. Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. Development 2013; 140:1397\u20131401.","journal-title":"Development"},{"key":"BFcr201669_CR28","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1210\/me.2013-1077","volume":"27","author":"AE Obr","year":"2013","unstructured":"Obr AE, Grimm SL, Bishop KA, Pike JW, Lydon JP, Edwards DP . Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. Mol Endocrinol 2013; 27:1808\u20131824.","journal-title":"Mol Endocrinol"},{"key":"BFcr201669_CR29","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.284.5418.1354","volume":"284","author":"S Fan","year":"1999","unstructured":"Fan S, Wang J, Yuan R, Rosen EM, et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 1999; 284:1354\u20131356.","journal-title":"Science"},{"key":"BFcr201669_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1210\/me.2004-0488","volume":"20","author":"Y Ma","year":"2006","unstructured":"Ma Y, Katiyar P, Jones LP, et al. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Mol Endocrinol 2006; 20:14\u201334.","journal-title":"Mol Endocrinol"},{"key":"BFcr201669_CR31","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1038\/sj.onc.1208426","volume":"24","author":"LP Jones","year":"2005","unstructured":"Jones LP, Li M, Halama ED, et al. Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene 2005; 24:3554\u20133562.","journal-title":"Oncogene"},{"key":"BFcr201669_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature12108","volume":"497","author":"H Dvinge","year":"2013","unstructured":"Dvinge H, Git A, Graf S, et al. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 2013; 497:378\u2013382.","journal-title":"Nature"},{"key":"BFcr201669_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-213X-1-4","volume":"1","author":"S Srinivas","year":"2001","unstructured":"Srinivas S, Watanabe T, Lin CS, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001; 1:4.","journal-title":"BMC Dev Biol"},{"key":"BFcr201669_CR34","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1038\/ncomms8736","volume":"6","author":"J Pencik","year":"2015","unstructured":"Pencik J, Schlederer M, Gruber W, et al. STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun 2015; 6:7736.","journal-title":"Nat Commun"},{"key":"BFcr201669_CR35","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1177\/0192623312454242","volume":"40","author":"D Rudmann","year":"2012","unstructured":"Rudmann D, Cardiff R, Chouinard L, et al. Proliferative and nonproliferative lesions of the rat and mouse mammary, Zymbal's, preputial, and clitoral glands. Toxicol Pathol 2012; 40:7S\u201339S.","journal-title":"Toxicol Pathol"},{"key":"BFcr201669_CR36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/sj.onc.1203277","volume":"19","author":"RD Cardiff","year":"2000","unstructured":"Cardiff RD, Anver MR, Gusterson BA, et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000; 19:968\u2013988.","journal-title":"Oncogene"},{"key":"BFcr201669_CR37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1158\/0008-5472.681.65.3","volume":"65","author":"MS Frech","year":"2005","unstructured":"Frech MS, Halama ED, Tilli MT, et al. Deregulated estrogen receptor a expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res 2005; 65:681\u2013685.","journal-title":"Cancer Res"},{"key":"BFcr201669_CR38","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/nm.1791","volume":"14","author":"P Eirew","year":"2008","unstructured":"Eirew P, Stingl J, Raouf A, et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 2008; 14:1384\u20131389.","journal-title":"Nat Med"},{"key":"BFcr201669_CR39","first-page":"249","volume":"290","author":"J Stingl","year":"2005","unstructured":"Stingl J, Emerman JT, Eaves CJ . Enzymatic dissociation and culture of normal human mammary tissue to detect progenitor activity. Methods Mol Biol 2005; 290:249\u2013263.","journal-title":"Methods Mol Biol"},{"key":"BFcr201669_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature13119","volume":"508","author":"X Chen","year":"2014","unstructured":"Chen X, Iliopoulos D, Zhang Q, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature 2014; 508:103\u2013107.","journal-title":"Nature"},{"key":"BFcr201669_CR41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrc3124","volume":"11","author":"S Kim","year":"2011","unstructured":"Kim S, You S, Hwang D . Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nat Rev Cancer 2011; 11:708\u2013718.","journal-title":"Nat Rev Cancer"},{"key":"BFcr201669_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.stemcr.2015.05.012","volume":"5","author":"PA Joshi","year":"2015","unstructured":"Joshi PA, Waterhouse PD, Kannan N, et al. RANK signaling amplifies WNT-responsive mammary progenitors through R-SPONDIN1. Stem Cell Reports 2015; 5:31\u201344.","journal-title":"Stem Cell Reports"},{"key":"BFcr201669_CR43","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/gb-2007-8-5-r76","volume":"8","author":"JI Herschkowitz","year":"2007","unstructured":"Herschkowitz JI, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007; 8:R76.","journal-title":"Genome Biol"},{"key":"BFcr201669_CR44","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD . The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 2012; 28:882\u2013883.","journal-title":"Bioinformatics"},{"key":"BFcr201669_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4137\/CIN.S9983","volume":"11","author":"X Chen","year":"2012","unstructured":"Chen X, Li J, Gray WH, et al. TNBCtype: a subtyping tool for triple-negative breast cancer. Cancer Inform 2012; 11:147\u2013156.","journal-title":"Cancer Inform"},{"key":"BFcr201669_CR46","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011; 121:2750\u20132767.","journal-title":"J Clin Invest"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cr201669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr201669","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr201669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:38:49Z","timestamp":1684402729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr201669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFcr201669"],"URL":"https:\/\/doi.org\/10.1038\/cr.2016.69","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]},"assertion":[{"value":"21 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}